Reports
Reports
Sale
The global clinical trials support services market size was valued at USD 22.49 billion in 2023, driven by the rising demand for new and advanced drugs, treatment therapies, and medical devices across the globe. The market size is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to achieve a value of USD 41.70 billion by 2032.
Clinical trials support services are specialized sets of services that are provided to pharmaceutical companies, researchers, and other organizations that are involved in clinical trials. Clinical trials are observational studies that are performed to learn about the efficacy, safety, and benefits associated with newly developed treatment therapies, drugs, and medical devices on human participants. Clinical trial support services provide help with functional tasks such as planning, execution, monitoring, and completion of clinical trials. These services can be provided by contract research organizations (CROs), research institutions, and academic centres, among other entities.
Technological advancement in the pharmaceutical sector and the development pipeline containing new drugs, treatment therapies, and medical devices, are resulting in an increased number of clinical trials, boosting the market growth. With intensifying interest in life sciences, the number of investment activities has also increased. Pharmaceutical companies are investing heavily towards the development of technologically advanced and innovative drugs and medical devices, that may potentially reduce the hassle of healthcare professionals. Such investments are anticipated to further intensify the global clinical trials support services market growth.
Additionally, the increasing popularity of advanced technologies and their advantages are also modifying the way clinical trials have always been performed. The integration of advanced technologies, such as artificial intelligence and machine learning, has improved the outcomes of clinical trials as their ability to process large amounts of data helps researchers propel the market growth. With the integration of such technologies, contract research organizations CROs and pharmaceutical companies are expected to partner with technology companies specializing in machine learning with a high probability of integrating machine learning algorithms in clinical trials. Such collaborations will further intensify the growth of the global market.
Market Breakup by Service Type
Market Braeakup by Phase
Market by Manufacturing Sponsor
Market Breakup by Region
The global market is anticipated to witness significant growth in the coming years as the rapid advancement of technologies and their integration in clinical trials is intensifying over time. Due to the integration of such technologies, the demand for clinical trials is surging in emerging economies, contributing to market growth. The market has also been witnessing a significant increase in the number of research and development activities and investments made by technology and pharmaceutical companies to improve the quality and outcomes of support services, further aiding the growth of the global clinical trials support services market value.
The increasing number of contract research organizations (CROs) in the market is also supporting the market growth as clinical trial support services can also be provided by CROs. The availability of CROs is also a major factor supporting the market growth. The expanded utilization of decentralized clinical trial models is also contributing to the global clinical trials support services market growth by providing more flexible and patient-centric study designs.
Geographically, North America is expected to rule the regional market supported by the high number of clinical trials being conducted in the region. The presence of key players, and research and development activities conducted by them with government support for clinical trials are some factors further promoting the market growth. The presence of key CROs offering clinical trial support services and multinational pharmaceutical and biopharmaceutical companies making major investments in clinical research are also contributing to the regional market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Service Type |
|
Breakup by Phase |
|
Breakup by Manufacturing Sponsor |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trials Support Services Market Overview
3.1 Global Clinical Trials Support Services Market Historical Value (2017-2023)
3.2 Global Clinical Trials Support Services Market Forecast Value (2024-2032)
4 Global Clinical Trials Support Services Market Landscape
4.1 Global Clinical Trials Support Services Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Clinical Trials Support Services Product Landscape
4.2.1 Analysis by Service Type
4.2.2 Analysis by Phase
4.2.3 Analysis by Sponsor
5 Global Clinical Trials Support Services Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trials Support Services Market Segmentation
6.1 Global Clinical Trials Support Services Market by Service Type
6.1.1 Market Overview
6.1.2 Clinical Trial Site Management
6.1.2.1 Patient Recruitment Management
6.1.2.2 Patient Recruitment and Registry Services
6.1.2.3 Patient Retention
6.1.2.4 Others
6.1.3 IRB
6.1.4 Data Management
6.1.5 Administrative staff
6.1.6 Others
6.2 Global Clinical Trials Support Services Market by Phase
6.2.1 Market Overview
6.2.2 Phase I
6.2.3 Phase II
6.2.4 Phase III
6.2.5 Phase IV
6.3 Global Clinical Trials Support Services Market by Manufacturing Sponsor
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biopharmaceutical
6.3.3 Medical Devices
6.3.4 Others
6.4 Global Clinical Trials Support Services Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Clinical Trials Support Services Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trials Support Services Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trials Support Services Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trials Support Services Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trials Support Services Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Charles River Laboratories International, Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Wuxi Apptec, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Iqvia Holdings, Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Syneos Health, Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Eurofins Scientific
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 Ppd, Inc. (Pharmaceutical Product Development)
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 Icon Plc
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 Laboratory Corporation Of America Holdings (Labcorp)
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 Alcura
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 Parexel International Corporation
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
17 Global Clinical Trials Support Services Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 22.49 billion in 2023, driven by the increasing awareness about the advantages of clinical trial support services.
The market is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 and is likely to reach a market value of USD 41.70 billion by 2032.
The adoption of digital patient engagement tools and increasing clinical trials are some of the major factors driving the market growth.
The increasing investments by pharmaceutical and technology companies and the increasing number of CROs are major factors influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The services offered in the market include clinical trial site management, which comprises of patient recruitment management, patient recruitment and registry services, and patient retention, among others. Other services are IRB, data management, administrative staff, and others.
There are four phases in the whole process, including phase I, phase II, phase III, and phase IV.
Manufacturing sponsors include pharmaceutical & biopharmaceuticals, and medical devices, among others.
Key players involved in the market are Charles River Laboratories International, Inc., Wuxi Apptec, Inc., Iqvia Holdings, Inc., Syneos Health, Inc., Eurofins Scientific, Ppd, Inc. (Pharmaceutical Product Development), Icon Plc, Laboratory Corporation Of America Holdings (Labcorp), Alcura, and Parexel International Corporation.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.